bMany successful antimicrobial drugs originate from synthetic dyes. This paper reports the in vitro activity of 14 fluorescent dyes against Plasmodium falciparum. Five of these dyes (Hoechst 33342, MitoRed, DiOC 6 , SYTO 9, and rhodamine B) show activity at a low nanomolar concentration against two P. falciparum strains in the histidine-rich protein 2 drug sensitivity assay, while toxicity in HeLa cells is low. These dyes may be a starting point for developing new drugs against P. falciparum.
The increasing resistance of Plasmodium falciparum to most drugs in clinical use and first reports of reduced sensitivity to artemisinin derivatives, the latest first-line drugs, made the development of new antimalarial compounds a research priority of utmost importance (20). Since existing drugs belong to only a few chemical classes, there is a high probability of the development of cross-resistance, which may shorten the product life of new drugs. In the history of drug discovery, many drugs were derived from synthetic dyes. Indeed, the pharmaceutical industry developed from the dye industry before World War II (22), and the antiplasmodial effect of dyes was shown more than a century ago by Guttman and Ehrlich (10), who cured two malaria patients with methylene blue. They were inspired to use methylene blue as an antimalarial drug after observing that it stains P. falciparum particularly well. Later, the antimalarial activity of other dyes such as rhodamine 123 (19), rhodamine B, Janus green (7), and eosin B (17) was discovered.With this work, we attempt to revive the use of staining properties as a preselection criterion for new antimalarial drugs. The use of dyes has several advantages: they accumulate in the target organism, they are easily screened for, and they belong to a large family of chemical entities not restricted to known pharmacophores. For this proof-of-concept study, we selected 14 different commercially available dyes staining mitochondria (MitoRed, MitoGreen, Daspei, DiOC 6 , rhodamine 123, rhodamine B, JC1, SYTO 18), nucleic acids (Hoechst 33342, acridine orange, SYBR green I, SYTO 9), or proteins (carboxyfluorescein diacetate [CFDA], CFDA-succinimidyl ester [CFDA-SE]). Dyes were obtained from the following sources. A yeast mitochondrial stain sampler kit containing DiOC 6 (CAS no. 53213-82-4), rhodamine B (hexyl ester perchlorate; CAS number not available), MitoGreen (MitoTracker Green FM; CAS no. 201860-17-5), and SYTO 18 (the structure is proprietary) was obtained from Invitrogen. The mitochondrial stains MitoRed (MitoTracker Red CMXRos; CAS no. 167095-09-2) and JC1 (CAS no. 47729-63-5) as well as the nucleic acid stains SYTO 9 (SYTO 9 green fluorescent nucleic acid stain; the structure is proprietary), Hoechst 33342 (CAS no. 23491-52-3), and acridine orange (CAS no. 65-61-2) were also from Invitrogen. Daspei (CAS no. 3785-01-1) was obtained from Biotium, CFDA (CAS no. 79955-27-4), CFDA-SE (CAS no. 150347-59-4), SYBR green I (CAS no. 163795-75-3), and chloroquine diphosphate (CAS no. 50-63-5) (molecu...